Related references
Note: Only part of the references are listed.Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Alberto Papi et al.
LANCET (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease A Nested Case-Control Study
Meng-Ting Wang et al.
JAMA INTERNAL MEDICINE (2018)
Initiation of triple therapy maintenance treatment among patients with COPD in the US
Jason C. Simeone et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study
Yogesh Suresh Punekar et al.
JOURNAL OF MEDICAL ECONOMICS (2017)
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Ntonio R. Anzueto et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
David A. Lipson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
Dave Singh et al.
RESPIRATORY RESEARCH (2017)
Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis
Yogesh Suresh Punekar et al.
RESPIRATORY RESEARCH (2017)
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies
Thomas M. Siler et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Dave Singh et al.
LANCET (2016)
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD
Gregory Feldman et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
Dave Singh et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies
Thomas M. Siler et al.
RESPIRATORY MEDICINE (2015)
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN studya randomised controlled trial
Peter A. Frith et al.
THORAX (2015)
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
Christine R. Jenkins et al.
BMC PULMONARY MEDICINE (2015)
Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use
Rajapriya Manickam et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Long-acting bronchodilators in COPD: where are we now and where are we going?
Mario Cazzola et al.
BREATHE (2014)
The Impact of Tiotropium on Mortality and Exacerbations When Added to Inhaled Corticosteroids and Long-Acting β-Agonist Therapy in COPD
Philip M. Short et al.
CHEST (2012)
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study
C. R. Jenkins et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Chris M. Kozma et al.
BMC PULMONARY MEDICINE (2011)
Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease
Todd A. Lee et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
J. Vestbo et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The role of long-acting bronchodilators in the management of stable COPD
DP Tashkin et al.
CHEST (2004)
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
BR Celli et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Share Paper
